Atomoxetine as an Adjunct to Novel Antipsychotic Medication in the Treatment of Cognitive Deficits of Schizophrenia
Completed · Not applicable
Conditions studied: Schizophrenia
In brief
The purpose of this study is to: * To examine wether adjunctive atomoxetine is more effective thank placebo for neuropsychological measures of reaction time, motor speed, psychomotor speed, sustained attention, learning and memory, working memory, and executive functioning. To determine the effect size of atomoxetine on these neuropsychological measures for follow-up studies. * To determine if atomoxetine has short-term benefits for improving weight gain and other metabolic abnormalities associated with antipsychotics.
Key facts
- Study ID
- NCT00161031
- Run by
- University of Maryland, Baltimore
- People needed
- 30
- Starts
- 2004-04-01
- Expected to finish
- 2006-12-01
- Last updated by the study team
- 2019-08-19
Who can join
Age: 18 and older, up to 60. Sex: any. Healthy volunteers: not accepted.
You may qualify if…
- DSM-IV diagnosis of either schizophrenia or schizoaffective disorder.
- Caucasian or Non-Caucasian.
- Subjects will be currently treated with one of the new generation antipsychotics: olanzapine, risperidone, quetiapine, or ziprasidone.
- Subjects will meet a prior criteria for cognitive impairment severity. The RBANS will be used to determine the level of cognitive impairment.
You may not qualify if…
- History of an organic brain disease.
- History of DSM-IV alcohol or substance abuse (within the last month), or DSM-IV alcohol or substance dependence (within the last six months).
- Pregnant women.
- Uncontrolled hypertension defined as high blood pressure exceeding 140/90 on three consecutive readings despite adequate treatment.
- Subjects receiving venlafaxine.
Where it is running
- Veterans Affairs Maryland Health Care System — Baltimore, Maryland, United States
- Maryland Psychiatric Research Center — Catonsville, Maryland, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.